SCHEMBL8429050

SCHEMBL8429050

CCCCCCCCCCCC(=O)NCCNCCO

nearest known ligand 0.66

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
NAAA Q02083 1/20 0.62
SELP P16109 1/20 0.62
FAAH O00519 4/20 0.61
CNR1 P21554 2/20 0.60
ALDH1A1 P00352 2/20 0.60
HPGD P15428 2/20 0.60
TRPV1 Q8NER1 1/20 0.60
MEN1 O00255 1/20 0.60
MAPT P10636 1/20 0.60
ALOX12 P18054 1/20 0.60
BLM P54132 1/20 0.60
KMT2A Q03164 1/20 0.60
TDP1 Q9NUW8 1/20 0.60
DNM1 Q05193 2/20 0.60
CASP2 P42575 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5418052 1.00 NAAA (0.62) NAAASELPFAAHCNR1ALDH1A1
SCHEMBL9633191 1.00 NAAA (0.62) NAAASELPFAAHCNR1ALDH1A1
SCHEMBL21170565 1.00 NAAA (0.62) NAAASELPFAAHCNR1ALDH1A1
Propionic Acid SCHEMBL28674969 0.94 SELP (0.56) NAAASELPFAAHCNR1ALDH1A1
SCHEMBL10038806 0.93 NAAA (0.62) NAAASELPFAAHCNR1ALDH1A1
SCHEMBL9633843 0.93 NAAA (0.56) NAAASELPFAAHCNR1ALDH1A1
SCHEMBL15463170 0.93 FAAH (0.69) NAAASELPFAAHCNR1ALDH1A1
SCHEMBL21682798 0.93 FAAH (0.69) NAAASELPFAAHCNR1ALDH1A1
SCHEMBL19513937 0.93 FAAH (0.69) NAAASELPFAAHCNR1ALDH1A1
SCHEMBL20801622 0.93 FAAH (0.69) NAAASELPFAAHCNR1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5869712-A α-amino-substituted acetic acids or acid salts and their use in cosmetics RHONE-POULENC CHIMIE (FR) 1999-02-09 US claimed
EP-0674616-B1 ALPHA-AMINO-SUBSTITUTED ACETIC ACID SALTS OR ACIDS AND COSMETIC USES THEREOF RHODIA CHIMIE SA (FR) 1998-07-29 EP claimed
US-12037541-B2 Anionic-cationic-nonionic surfactant, production and use thereof CHINA PETROLEUM & CHEMICAL CORPORATION (CN) 2024-07-16 US disclosed
US-20220033705-A1 ANIONIC-CATIONIC-NONIONIC SURFACTANT, PRODUCTION AND USE THEREOF CHINA PETROLEUM & CHEMICAL CORPORATION (CN) 2022-02-03 US disclosed
US-11186764-B2 Anionic-cationic-nonionic surfactant, production and use thereof CHINA PETROLEUM & CHEMICAL CORPORATION (CN) 2021-11-30 US disclosed
US-20190330516-A1 ANIONIC-CATIONIC-NONIONIC SURFACTANT, PRODUCTION AND USE THEREOF CHINA PETROLEUM & CHEMICAL CORPORATION (CN) 2019-10-31 US disclosed
US-10400156-B2 Anionic-cationic-nonionic surfactant, production and use thereof CHINA PETROLEUM & CHEMICAL CORPORATION (CN) 2019-09-03 US disclosed
US-20170313928-A1 ANIONIC-CATIONIC-NONIONIC SURFACTANT,PRODUCTION AND USE THEREOF CHINA PETROLEUM & CHEMICAL CORPORATION (CN) 2017-11-02 US disclosed
CN-105642185-A Anionic-cationic-nonionic surfactant, preparation method therefor and application of anionic-cationic-nonionic surfactant 中国石油化工股份有限公司 2016-06-08 CN disclosed
US-5869712-A α-amino-substituted acetic acids or acid salts and their use in cosmetics RHONE-POULENC CHIMIE (FR) 1999-02-09 US disclosed
EP-0472107-B1 Cationic compound and cleaning composition KAO CORP (JP) 1994-12-14 EP disclosed
US-5318727-A Reacting cyclic amidine and/or acyclic amideamine with cationizing quaternary amine compound KAO CORPORATION (JP) 1994-06-07 US disclosed
US-5162315-A Topical administration of diltiazem THERAPEUTIC PATCH RESEARCH N.V. 1992-11-10 US disclosed
EP-0472107-A2 Cationic compound and cleaning composition KAO CORPORATION (JP) 1992-02-26 EP disclosed
EP-0269940-B1 SURFACE ACTIVE AGENT AND PROCESS FOR PREPARING THE SAME Kao Corporation (JP) 1991-12-04 EP disclosed
US-4885112-A CONTAINING LOW PERCENTAGE OF INORGANIC SALT; COMPATIBILITY, STABILITY KAO CORPORATION (JP) 1989-12-05 US disclosed
US-4705893-A IMIDAZOLINES KAO CORPORATION (JP) 1987-11-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190330516-A1 ANIONIC-CATIONIC-NONIONIC SURFACTANT, PRODUCTION AND USE THEREOF LIPA, ABHD12, ABHD16A NAAA 94/4885SELP 635/4885FAAH 295/4885
US-12037541-B2 Anionic-cationic-nonionic surfactant, production and use thereof LIPA, SGMS1, AQP1 NAAA 108/4885SELP 998/4885FAAH 220/4885
US-11186764-B2 Anionic-cationic-nonionic surfactant, production and use thereof LIPA, ABHD12, ABHD16A NAAA 94/4885SELP 635/4885FAAH 295/4885
US-20220033705-A1 ANIONIC-CATIONIC-NONIONIC SURFACTANT, PRODUCTION AND USE THEREOF LIPA, ABHD16A, ABHD12 NAAA 78/4885SELP 719/4885FAAH 258/4885
US-10400156-B2 Anionic-cationic-nonionic surfactant, production and use thereof LIPA, ABHD12, ABHD16A NAAA 94/4885SELP 635/4885FAAH 295/4885
US-20170313928-A1 ANIONIC-CATIONIC-NONIONIC SURFACTANT,PRODUCTION AND USE THEREOF LIPA, ABHD12, ABHD16A NAAA 94/4885SELP 635/4885FAAH 295/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.